Login to Your Account



Summit Moving Lead Drugs with Wellcome Trust Award

By Nuala Moran
Staff Writer

Tuesday, October 23, 2012

LONDON – Summit plc is making headway with its two lead programs, winning a £4 million (US$6.42 million) translation award from the Wellcome Trust for clinical trials of SMT19969, a narrow-spectrum antibiotic for treating Clostridium difficile infections.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription